← All companies
About this company
Nerai Bio is advancing the frontier of genome editing with a new generation of ultra-precise CRISPR enzymes engineered to unlock genomic targets beyond the reach of existing technologies. Our proprietary MORPHEME platform combines AI and high-throughput protein engineering via directed evolution to design bespoke genome editors with unmatched specificity and therapeutic potential. Our mission is to create a world where no genetic disease is too rare, too hard, or too complex to cure. At Nerai, we don’t just edit DNA—we aim to rewrite the future of patients.